Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Fractional flow reserve is a procedure used in coronary catheterization to measure the difference in pressure across coronary artery stenosis. This technique is calculated as mean distal coronary pressure divided by mean aortic pressure during maximal pharmacological vasodilation. The technique helps physician to decide whether optimal medical therapy alone versus revascularization (percutaneous coronary intervention or coronary artery bypass grafting) is more appropriate on a lesion by lesion basis. For instance the intermediate blockage in coronary artery disease has been a challenge for interventional cardiologists to determine the appropriate use of angioplasty and stenting. Fractional Flow Reserve (FFR) offers yet another tool to help identify intermediate blockages. Moreover, FFR is used a standard diagnostic catheter at the time of a coronary angiogram or cardiac catheterization.
The key factor driving the growth of fractional flow reserve market is growing incidence of coronary artery diseases and diabetes. For instance about 18.2 million adults age 20 and older have CAD (about 6.7%) and 2 in 10 deaths from CAD happen in adults less than 65 years old which further demand for the innovative fractional flow reserve devices in market. Besides rising geriatric population is propelling the growth of fractional flow reserve market as the population has major risk to cardiovascular diseases and chronic diseases such as diabetes
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the fractional flow reserve market. In addition, complete analysis of changes on the fractional flow reserve market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 impact on fractional flow reserve market was moderate as the pandemic has majority manufacturing production shut down for few months which has ultimately hamper the growth of market till some extend
The fractional flow reserve market is segmented based on by technology, by application and geography.
Depending on the technology the fractional flow reserve is available in invasive monitoring, non-invasive monitoring
Invasive Monitoring is further bifurcated to ffr measurement systems and pressure guidewires. The invasive monitoring dominated the global fractional flow reserve market. This invasive monitoring provides more in depth understanding of patient’s condition which further helps for correct diagnosis. Moreover, allows for adjustment of treatment in appropriate manner and provides continuous access for regular blood samples. Also, this invasive monitoring utilizes pressure guide wires and monitoring systems for the measurement of fractional flow reserve which further fuel the demand for fractional flow reserve market
Fractional flow reserve finds applications in single-vessel diseases, multi-vessel diseases
Single vessel disease is anticipated t leads in the market owing to growing cases of single-vessel coronary artery disease among geriatric population. For instance, the single vessel disease is major observed in male (76.9%) than in female. Besides multi vessel diseases is expected to witness the highest growth during the forecast period as the multi-vessel disease patients have worse post procedural outcomes, increased complications, length of hospital stays, higher referral for CABG and in hospital mortality
Geographically the global fractional flow reserve market is studied for following region North America, Europe, Asia Pacific and RoW.
North America leads in the global fractional flow reserve market due to developing healthcare infrastructure. In addition growing geriatric population and prevalence of chronic disease is further increasing the demand for fractional flow reserve devices. Also, government policies and growing mergers and acquisitions by key players is propelling the growth of region in the global fractional flow reserve market. On the other hand Asia Pacific is anticipated to witness significant growth during the forecast period. The growth is attributed to increasing disease cases of diabetes and cardiovascular. Moreover, rise in disposable income is further fueling the growth of Asia Pacific region in global fractional flow reserve market
The major players in fractional flow reserve market are Abbott Laboratories, Koninklijke Philips N.V., Boston Scientific Corporation, Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc), Opsens, Inc., Heartflow, Inc., Siemens Healthineers, Pie Medical Imaging, Cathworks, Medis Medical Imaging Systems Bv, Medtronic PLC and Terumo Corporation among others.
The report analyses the global fractional flow reserve market based on by technology, by application and geography. Depending on the technology the fractional flow reserve is available in invasive monitoring, non-invasive monitoring. Fractional flow reserve finds applications in single-vessel diseases, multi-vessel diseases. Geographically the global fractional flow reserve market is studied for following region North America, Europe, Asia Pacific and RoW.
The major players in fractional flow reserve market are Abbott Laboratories, Koninklijke Philips N.V., Boston Scientific Corporation, Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc), Opsens, Inc., Heartflow, Inc., Siemens Healthineers, Pie Medical Imaging, Cathworks, Medis Medical Imaging Systems Bv, Medtronic PLC and Terumo Corporation among others.
Why to buy this report:
